9,421 Shares in Perrigo Company plc (NYSE:PRGO) Bought by iSAM Funds UK Ltd

iSAM Funds UK Ltd bought a new position in shares of Perrigo Company plc (NYSE:PRGO) in the fourth quarter, Holdings Channel.com reports. The fund bought 9,421 shares of the company’s stock, valued at approximately $242,000.

A number of other hedge funds have also bought and sold shares of the company. Headlands Technologies LLC grew its stake in shares of Perrigo by 1,942.0% in the 4th quarter. Headlands Technologies LLC now owns 1,409 shares of the company’s stock valued at $36,000 after buying an additional 1,340 shares during the period. Venturi Wealth Management LLC grew its stake in shares of Perrigo by 97.8% in the 4th quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company’s stock valued at $108,000 after buying an additional 2,084 shares during the period. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Perrigo in the 4th quarter valued at about $149,000. State of Wyoming grew its stake in shares of Perrigo by 21.9% in the 4th quarter. State of Wyoming now owns 8,002 shares of the company’s stock valued at $206,000 after buying an additional 1,440 shares during the period. Finally, Sterling Capital Management LLC grew its stake in shares of Perrigo by 51.8% in the 4th quarter. Sterling Capital Management LLC now owns 8,144 shares of the company’s stock valued at $209,000 after buying an additional 2,780 shares during the period. Institutional investors own 95.91% of the company’s stock.

Insider Buying and Selling at Perrigo

In other news, EVP Ronald Craig Janish sold 7,800 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the transaction, the executive vice president now owns 33,666 shares in the company, valued at $923,795.04. The trade was a 18.81% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.70% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com downgraded Perrigo from a “buy” rating to a “hold” rating in a research note on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $33.00.

Perrigo Price Performance

PRGO stock opened at $27.42 on Wednesday. The company has a market capitalization of $3.77 billion, a P/E ratio of -23.44 and a beta of 0.45. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.77 and a current ratio of 2.56. Perrigo Company plc has a 52-week low of $23.14 and a 52-week high of $30.93. The business has a 50-day simple moving average of $26.26 and a two-hundred day simple moving average of $26.17.

Perrigo (NYSE:PRGO) last released its quarterly earnings results on Wednesday, May 7th. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.56 by $0.04. The business had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.09 billion. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The company’s quarterly revenue was down 3.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.29 EPS. Research analysts expect that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Friday, May 30th will be paid a dividend of $0.29 per share. The ex-dividend date is Friday, May 30th. This represents a $1.16 dividend on an annualized basis and a yield of 4.23%. Perrigo’s dividend payout ratio (DPR) is currently -88.55%.

Perrigo Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.